Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131738) titled 'A randomized controlled trial comparing the efficacy and safety of Hybutimibe Tablets plus atorvastatin versus atorvastatin in the treatment of chronic kidney disease with hypercholesterolemia' on Sept. 6.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shantou Central Hospital
Condition:
chronic kidney disease complicated by hypercholesterolemia
Intervention:
control group:Treatment with atorvastatin
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-03-01
Target Sample Size: control group:200;Experimental Group:200;
Countries of Recruitment:
China...